Aminologics Co.,Ltd. (KOSDAQ:074430)
South Korea
· Delayed Price · Currency is KRW 954.00
+3.00 (0.32%)
Last updated: Jun 25, 2025
Aminologics Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Other Revenue | - | - | - | -0 | -0 | - | Upgrade
|
| Revenue | 16,581 | 16,790 | 20,887 | 27,337 | 22,849 | 17,651 | Upgrade
|
| Revenue Growth (YoY) | -23.68% | -19.61% | -23.60% | 19.64% | 29.45% | -7.00% | Upgrade
|
| Cost of Revenue | 12,728 | 13,406 | 13,153 | 14,547 | 13,721 | 10,676 | Upgrade
|
| Gross Profit | 3,853 | 3,384 | 7,734 | 12,790 | 9,128 | 6,975 | Upgrade
|
| Selling, General & Admin | 4,930 | 4,966 | 4,527 | 5,179 | 4,255 | 3,912 | Upgrade
|
| Research & Development | 160.89 | 112.54 | 1,307 | 215.51 | 474.13 | 339.66 | Upgrade
|
| Other Operating Expenses | 23.46 | -6.05 | -8.14 | 9.56 | 16.06 | 19.89 | Upgrade
|
| Operating Expenses | 5,593 | 5,537 | 6,272 | 5,881 | 5,174 | 4,391 | Upgrade
|
| Operating Income | -1,740 | -2,153 | 1,462 | 6,908 | 3,953 | 2,584 | Upgrade
|
| Interest Expense | -83.72 | -83.42 | -57.08 | -40.01 | -30.92 | -36.32 | Upgrade
|
| Interest & Investment Income | 1,137 | 1,175 | 929.76 | 525.7 | 198.06 | 254.86 | Upgrade
|
| Currency Exchange Gain (Loss) | 444.96 | 879.8 | -75.28 | 397.24 | 465.53 | -359.73 | Upgrade
|
| Other Non Operating Income (Expenses) | 54.24 | 42.61 | 133.25 | 105.51 | -8.26 | 328.19 | Upgrade
|
| EBT Excluding Unusual Items | -187.61 | -138.97 | 2,393 | 7,897 | 4,578 | 2,771 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1,038 | 11.98 | -101.82 | -659.69 | 658.99 | -696.82 | Upgrade
|
| Gain (Loss) on Sale of Assets | 8.41 | 8.41 | - | - | - | - | Upgrade
|
| Asset Writedown | -986 | -986 | - | -13,518 | -1,533 | - | Upgrade
|
| Pretax Income | -126.87 | -1,105 | 2,291 | -6,281 | 3,704 | 2,074 | Upgrade
|
| Income Tax Expense | 453.69 | 515.44 | -145.31 | 1,001 | -1,656 | -66 | Upgrade
|
| Net Income | -580.56 | -1,620 | 2,436 | -7,282 | 5,360 | 2,140 | Upgrade
|
| Net Income to Common | -580.56 | -1,620 | 2,436 | -7,282 | 5,360 | 2,140 | Upgrade
|
| Net Income Growth | - | - | - | - | 150.46% | - | Upgrade
|
| Shares Outstanding (Basic) | 88 | 88 | 88 | 88 | 88 | 88 | Upgrade
|
| Shares Outstanding (Diluted) | 88 | 88 | 88 | 88 | 88 | 88 | Upgrade
|
| EPS (Basic) | -6.61 | -18.45 | 27.74 | -82.91 | 61.03 | 24.37 | Upgrade
|
| EPS (Diluted) | -6.61 | -18.45 | 27.74 | -82.91 | 61.03 | 24.37 | Upgrade
|
| EPS Growth | - | - | - | - | 150.46% | - | Upgrade
|
| Free Cash Flow | 1,273 | 6,955 | -373.95 | 4,736 | 419.81 | 1,460 | Upgrade
|
| Free Cash Flow Per Share | 14.49 | 79.19 | -4.26 | 53.92 | 4.78 | 16.62 | Upgrade
|
| Gross Margin | 23.24% | 20.16% | 37.03% | 46.79% | 39.95% | 39.52% | Upgrade
|
| Operating Margin | -10.50% | -12.82% | 7.00% | 25.27% | 17.30% | 14.64% | Upgrade
|
| Profit Margin | -3.50% | -9.65% | 11.66% | -26.64% | 23.46% | 12.12% | Upgrade
|
| Free Cash Flow Margin | 7.68% | 41.42% | -1.79% | 17.32% | 1.84% | 8.27% | Upgrade
|
| EBITDA | -1,262 | -1,688 | 1,908 | 7,259 | 4,232 | 2,811 | Upgrade
|
| EBITDA Margin | -7.61% | -10.05% | 9.14% | 26.55% | 18.52% | 15.92% | Upgrade
|
| D&A For EBITDA | 478.62 | 465.43 | 446.15 | 350.84 | 278.81 | 226.97 | Upgrade
|
| EBIT | -1,740 | -2,153 | 1,462 | 6,908 | 3,953 | 2,584 | Upgrade
|
| EBIT Margin | -10.50% | -12.82% | 7.00% | 25.27% | 17.30% | 14.64% | Upgrade
|
| Advertising Expenses | - | 132.5 | 91.26 | 26.12 | 63.09 | 45.2 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.